Literature DB >> 15219717

Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse.

Mari S Golub1, Stacey L Germann, K C Kent Lloyd.   

Abstract

ErbB4 is an important brain receptor for the neuregulin1 growth factor. A conditional knock-out mouse was developed lacking both alleles of the erbB4 gene in neurons/glia, and one allele in other cells. The conditional mutant mice were compared to heterozygous null (one null allele and one wildtype allele in all tissues) and wildtype control (no gene deletion) littermates in a battery of behavioral tests. Conditional mutants displayed a lower level of spontaneous motor activity and reduced grip strength compared to wildtype control mice. Group mean scores of heterozygous nulls were intermediate on these measures. However, heterozygous nulls were delayed in motor development and male heterozygous nulls demonstrated altered cue use in a Morris maze learning and memory task relative to both wildtype control and conditional mutant mice. These findings were interpreted based on more detailed analysis of the behavioral data and considerations of the complex nature and multiple roles of the neuregulin/erbB4 system in the nervous system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15219717     DOI: 10.1016/j.bbr.2003.11.010

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  67 in total

Review 1.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

Authors:  Judith Pratt; Catherine Winchester; Neil Dawson; Brian Morris
Journal:  Nat Rev Drug Discov       Date:  2012-06-22       Impact factor: 84.694

2.  Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons.

Authors:  A Ledonne; A Nobili; E C Latagliata; V Cavallucci; E Guatteo; S Puglisi-Allegra; M D'Amelio; N B Mercuri
Journal:  Mol Psychiatry       Date:  2014-09-30       Impact factor: 15.992

Review 3.  Glial cells in schizophrenia: a unified hypothesis.

Authors:  Andrea G Dietz; Steven A Goldman; Maiken Nedergaard
Journal:  Lancet Psychiatry       Date:  2019-11-06       Impact factor: 27.083

4.  A Central Extended Amygdala Circuit That Modulates Anxiety.

Authors:  Sandra Ahrens; Melody V Wu; Alessandro Furlan; Ga-Ram Hwang; Raehum Paik; Haohong Li; Mario A Penzo; Jessica Tollkuhn; Bo Li
Journal:  J Neurosci       Date:  2018-05-29       Impact factor: 6.167

Review 5.  Postmortem brain: an underutilized substrate for studying severe mental illness.

Authors:  Robert E McCullumsmith; John H Hammond; Dan Shan; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2013-10-04       Impact factor: 7.853

6.  ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms.

Authors:  Daria Krivosheya; Lucia Tapia; Joshua N Levinson; Kun Huang; Yunhee Kang; Rochelle Hines; Annie K Ting; Ann Marie Craig; Lin Mei; Shernaz X Bamji; Alaa El-Husseini
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

Review 7.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

8.  Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons.

Authors:  Lei Wen; Yi-Sheng Lu; Xin-Hong Zhu; Xiao-Ming Li; Ran-Sook Woo; Yong-Jun Chen; Dong-Min Yin; Cary Lai; Alvin V Terry; Almira Vazdarjanova; Wen-Cheng Xiong; Lin Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-29       Impact factor: 11.205

9.  Early myoclonic encephalopathy caused by a disruption of the neuregulin-1 receptor ErbB4.

Authors:  Liesbeth Backx; Berten Ceulemans; Joris Robert Vermeesch; Koen Devriendt; Hilde Van Esch
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

10.  Expressions of neuregulin 1beta and ErbB4 in prefrontal cortex and hippocampus of a rat schizophrenia model induced by chronic MK-801 administration.

Authors:  Yu Feng; Xiao-Dong Wang; Chun-Mei Guo; Yang Yang; Ji-Tao Li; Yun-Ai Su; Tian-Mei Si
Journal:  J Biomed Biotechnol       Date:  2010-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.